The CEA Registry Blog

Jan 17

by CEA Registry Team 1/17/2012 12:20 PM  RssIcon

Twice each month we highlight recently published cost-utility studies and selected reviews and editorials.

1. Farnham PG, Sansom SL, Hutchinson AB. How Much Should We Pay for a New HIV Diagnosis? A Mathematical Model of HIV Screening in US Clinical Settings. Med Decis Making. 2012 Jan 12. [Epub ahead of print] PubMed PMID: 22247422.

2. Roberts TE, Barton PM, Auguste PE, Middleton LJ, Furmston AT, Ewer AK. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis. Arch Dis Child. 2012 Jan 13. [Epub ahead of print]PubMed PMID: 22247242.

3. Cucchetti A, Trevisani F, Cescon M, et al. Cost-effectiveness of semiannual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. J Hepatol. 2012 Jan 12. [Epub ahead of print] PubMed PMID: 22245900.

4. Coupé VM, Bogaards JA, Meijer CJ, et al. Impact of vaccine protection against multiple HPV types on the cost-effectiveness of cervical screening. Vaccine. 2012 Jan 9. [Epub ahead of print] PubMed PMID: 22240341.

5. Dinh TA, Alperin P, Walter LC, et al. Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectiveness Study in Diabetic Populations. J Gen Intern Med. 2012 Jan 12. [Epub ahead of print] PubMed PMID: 22237663.

6. Rein DB, Wittenborn JS, Zhang X, et al. The Cost-effectiveness of Welcome to Medicare Visual Acuity Screening and a Possible Alternative Welcome to Medicare Eye Evaluation Among Persons Without Diagnosed Diabetes Mellitus. Arch Ophthalmol. 2012 Jan 9. [Epub ahead of print] PubMed PMID: 22232367.

7. Lazenby GB, Unal ER, Andrews AL, et al. A Cost-Effectiveness Analysis of Anal Cancer Screening in HIV-Positive Women. J Low Genit Tract Dis. 2012 Jan 5.[Epub ahead of print] PubMed PMID: 22227844.

8. Wallerstedt SM, Bladh L, Ramsberg J. A cost-effectiveness analysis of an in-hospital clinical pharmacist service. BMJ Open. 2012 Jan 5;2:e000329. Print 2012. PubMed PMID: 22223840.

9. Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012 Jan 6. [Epub ahead of print] PubMed PMID: 22222755.

10. Coleman CI, Straznitskas AD, Sobieraj DM, et al. Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable. Am J Cardiol. 2012 Jan 3. [Epub ahead of print] PubMed PMID: 22221944.

11. Tanaka H, Iijima H, Nouso K, et al. Cost-effectiveness analysis on the surveillance for hepatocellular carcinoma in liver cirrhosis patients using contrast-enhanced ultrasonography. Hepatol Res.2012 Jan 3. [Epub ahead of print] PubMed PMID: 22221694.

12. Sánchez-de la Rosa R, Sabater E, Casado M, et al. Cost-effectiveness Analysis of Disease Modifiying Drugs (Interferons and Glatiramer Acetate) as first line treatments in Remitting-Relapsing Multiple Sclerosis patients. J Med Econ. 2012 Jan 5. [Epub ahead of print] PubMed PMID: 22217249.

13. Schackman BR, Leff JA, Polsky D, et. Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care. J Gen Intern Med. 2012 Jan 4. [Epub ahead of print] PubMed PMID: 22215271.

14. Gillespie P, O'Neill C, Adams E, et al. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Sex Transm Infect. 2012 Jan 2. [Epub ahead of print] PubMed PMID: 22213681.

15. Gatwood J, Meltzer MI, Messonnier M, et al. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 2012 Jan 1;72(1):35-48. PubMed PMID: 22191794.

16. Athanasakis K, Souliotis K, Tountas Y, Kyriopoulos J, Hatzakis A. A cost-utility analysis of hypertension treatment in Greece: assessing the impact of age, sex and smoking status, on outcomes. J Hypertens. 2012 Jan;30(1):227-34. PubMed PMID: 22157591.

17. Hall PS, McCabe C, Stein RC, et al. Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer. J Natl Cancer Inst. 2012 Jan 4;104(1):56-66. Epub 2011 Dec 2. PubMed PMID: 22138097.

18. McKenna C, Maund E, Sarowar M, et al. Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal. Pharmacoeconomics. 2012 Jan 1;30(1):35-46. PubMed PMID: 22136303.

19.Bilcke J, Marais C, Ogunjimi B, et al. Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. Vaccine. 2012 Jan 11;30(3):675-84. Epub 2011 Nov 24. PubMed PMID: 22120193.

20. Chen HW, Bercik RS, Werner EF, et al. Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder. J Urol. 2012 Jan;187(1):178-84. Epub 2011 Nov 17. PubMed PMID: 22100006.

21. Heilbrun ME, Yu J, Smith KJ, Dechet et al. The cost-effectiveness of immediate treatment, percutaneous biopsy and active surveillance for the diagnosis of the small solid renal mass: evidence from a markov model. J Urol. 2012 Jan;187(1):39-43. Epub 2011 Nov 16. PubMed PMID: 22088331.

22. Gurusamy K, Wilson E, Burroughs AK, et al. Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis. Appl Health Econ Health Policy. 2012 Jan 1;10(1):15-29. PubMed PMID: 22077427.

23. Hultman B, Lundkvist J, Glimelius B, et al. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta Oncol. 2012 Jan;51(1):112-21. Epub 2011 Nov 10. PubMed PMID: 22070666.

24. Grzeszczak W, Czupryniak L, Kolasa K, et al. The Cost-Effectiveness of Saxagliptin Versus NPH Insulin When Used in Combination with Other Oral Antidiabetes Agents in the Treatment of Type 2 Diabetes Mellitus in Poland. Diabetes Technol Ther. 2012 Jan;14(1):65-73. Epub 2011 Nov 8. PubMed PMID: 22066527.

25. Partridge JC, Sendowski MD, Martinez AM, et al. Resuscitation of likely nonviable infants: a cost-utility analysis after the Born-Alive Infant Protection Act. Am J Obstet Gynecol. 2012 Jan;206(1):49.e1-49.e10. Epub 2011 Sep 24. PubMed PMID: 22051817.

26. Hersey JC, Khavjou O, Strange LB, et al. The efficacy and cost effectiveness of a community weight management intervention: A randomized controlled trial of the health weight management demonstration. Prev Med. 2012 Jan 1;54(1):42-9. Epub 2011 Oct 6. PubMed PMID: 22001689.

27. Resch B, Sommer C, Nuijten MJ, et al. Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria. Pediatr Infect Dis J. 2012 Jan;31(1):e1-8. PubMed PMID: 21960187.

28. Cooper MS, Palmer AJ, Seibel MJ. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int. 2012 Jan;23(1):97-107. Epub 2011 Sep 28. PubMed PMID: 21953475.

29. Retèl VP, Joore MA, van Harten WH. Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance. Breast Cancer Res Treat. 2012 Jan;131(2):627-36. Epub 2011 Sep 24. PubMed PMID: 21947677.

30. Rosas SE, Feldman HI. Synthetic vascular hemodialysis access versus native arteriovenous fistula: a cost-utility analysis. Ann Surg. 2012 Jan;255(1):181-6. PubMed PMID: 21918428.

31. Lavelle TA, Uyeki TM, Prosser LA. Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza. J Pediatr. 2012 Jan;160(1):67-73.e6. Epub 2011 Sep 13. PubMed PMID: 21917267.

32. Martin NK, Vickerman P, Miners A, et al. Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations. Hepatology. 2012 Jan;55(1):49-57. Epub 2011 Dec 6. PubMed PMID: 21898506.

33. Saariniemi KM, Kuokkanen HO, Räsänen P, et al. The cost-utility of reduction mammaplasty at medium-term follow-up: A prospective study. J Plast Reconstr Aesthet Surg. 2012 Jan;65(1):17-21. Epub 2011 Aug 27. PubMed PMID: 21873127.

34. Yamamoto N, Mori R, Jacklin P, et al. Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis. BJOG. 2012 an;119(2):177-86Epub 2011 Jul 28. PubMed PMID: 21794070.

35. Havrilesky LJ, Pokrzywinski R, Revicki D, et al. Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer. Cancer. 2012 Jan 15;118(2):386-91. Epub 2011 May 19. PubMed PMID: 21598242.

By Teja Thorat


Your name:
Security Code
Enter the code shown above in the box below
Add Comment   Cancel 

Please view the blog archive for earlier entries

Search This Blog